NUVB

Nuvation Bio Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 1/10
  • Value↓ 0/10
Nuvation Bio sales and earnings growth
NUVB Growth
Low
  • Revenue Y/Y↑ 1205.52%
  • EPS Y/Y↑ 80.91%
  • FCF Y/Y↑ 19.98%
Nuvation Bio gross and profit margin trends
NUVB Profitability
Neutral
  • Gross margin ↑ 90.80%
  • EPS margin↓ -102.10%
  • ROIC 5Y↓ -52.48%
Nuvation Bio net debt vs free cash flow
NUVB Risk
Great
  • Debt / Equity↓ 0.7
  • Debt / FCF↓ 0.7
  • Interest coverage↓ -6.2

Nuvation Bio stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks